Skip to main navigation Skip to search Skip to main content

A Multicenter, Multi-Arm, Randomized, Multi-Dose, Placebo-Controlled, Double-Blind, Phase 3 Study of Intravesical Apaziquone (EOquin) as a Surgical Adjuvant in the Immediate Postoperative Period in Patients Undergoing Transurethral . . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/19/16 → 05/3/17

Funding

  • Spectrum Pharmaceuticals Incorporated: $12,750.00